Synerkine Pharma
Utrecht
About Synerkine Pharma
Synerkine Pharma focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company's protein targets common regulatory mechanisms in different types of chronic pain and has unique properties, enabling patients to effectively reduce pain in multiple pre-clinical models.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $13.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2023)
- Website: synerkinepharma.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/synerkine-pharma-67169 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.